Total Payments
$3,937
2024 Payments
$1,487
Companies
26
Transactions
189
Medicare Patients
113
Medicare Billing
$9,458
Payment Breakdown by Category
Food & Beverage$3,937 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,937 | 189 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Abbott Laboratories | $970.86 | 56 | $0 (2024) |
| ABBVIE INC. | $690.06 | 33 | $0 (2024) |
| Janssen Biotech, Inc. | $402.43 | 15 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $366.17 | 17 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $307.81 | 23 | $0 (2024) |
| Celgene Corporation | $151.82 | 8 | $0 (2024) |
| PFIZER INC. | $148.16 | 6 | $0 (2024) |
| Janssen Scientific Affairs, LLC | $129.79 | 1 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $121.87 | 1 | $0 (2022) |
| Lilly USA, LLC | $81.75 | 3 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,487 | 68 | Takeda Pharmaceuticals U.S.A., Inc. ($238.88) |
| 2023 | $976.80 | 45 | ABBVIE INC. ($247.64) |
| 2022 | $1,044 | 43 | Abbott Laboratories ($344.19) |
| 2021 | $428.87 | 33 | Abbott Laboratories ($411.50) |
All Payment Transactions
189 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $23.68 | General |
| Category: INTERNAL MEDICINE | ||||||
| 12/03/2024 | Intercept Pharmaceuticals, Inc. | OCALIVA (Drug) | Food and Beverage | In-kind items and services | $18.09 | General |
| Category: Hepatology / Gastroenterology | ||||||
| 11/27/2024 | Ipsen Biopharmaceuticals, Inc | IQIRVO (Drug) | Food and Beverage | In-kind items and services | $20.33 | General |
| Category: Rare Disease | ||||||
| 11/26/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $28.63 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/21/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $13.35 | General |
| Category: IMMUNOLOGY | ||||||
| 11/13/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $17.73 | General |
| Category: LIVER DISEASE | ||||||
| 11/11/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $21.46 | General |
| Category: Gastroenterology | ||||||
| 10/29/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $21.18 | General |
| Category: LIVER DISEASE | ||||||
| 10/23/2024 | Takeda Pharmaceuticals U.S.A., Inc. | GATTEX (Drug) | Food and Beverage | In-kind items and services | $14.30 | General |
| Category: INTERNAL MEDICINE | ||||||
| 10/21/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $34.94 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/09/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $25.11 | General |
| Category: IMMUNOLOGY | ||||||
| 10/08/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $25.46 | General |
| Category: IMMUNOLOGY | ||||||
| 10/02/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $19.03 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/26/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $9.73 | General |
| Category: Gastroenterology | ||||||
| 09/25/2024 | Intercept Pharmaceuticals, Inc. | OCALIVA (Drug) | Food and Beverage | In-kind items and services | $13.76 | General |
| Category: Hepatology / Gastroenterology | ||||||
| 09/24/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $29.55 | General |
| Category: INTERNAL MEDICINE | ||||||
| 09/23/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $21.25 | General |
| Category: LIVER DISEASE | ||||||
| 09/19/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $22.91 | General |
| Category: Neuroscience | ||||||
| 09/18/2024 | Merck Sharp & Dohme LLC | DIFICID (Drug) | Food and Beverage | In-kind items and services | $21.18 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 09/18/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $19.49 | General |
| Category: IMMUNOLOGY | ||||||
| 09/04/2024 | Intercept Pharmaceuticals, Inc. | OCALIVA (Drug) | Food and Beverage | In-kind items and services | $16.66 | General |
| Category: Hepatology / Gastroenterology | ||||||
| 08/28/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $24.48 | General |
| Category: INTERNAL MEDICINE | ||||||
| 08/28/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $16.90 | General |
| Category: Gastroenterology | ||||||
| 08/27/2024 | Takeda Pharmaceuticals U.S.A., Inc. | GATTEX (Drug) | Food and Beverage | In-kind items and services | $21.00 | General |
| Category: INTERNAL MEDICINE | ||||||
| 08/21/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $34.91 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 92 | 110 | $21,386 | $7,533 |
| 2022 | 1 | 21 | 23 | $4,991 | $1,925 |
Total Patients
113
Total Services
133
Medicare Billing
$9,458
Procedure Codes
3
All Medicare Procedures & Services
3 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 60 | 74 | $16,058 | $5,644 | 35.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 32 | 36 | $5,328 | $1,889 | 35.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 21 | 23 | $4,991 | $1,925 | 38.6% |
About Hania Tofik
Hania Tofik is a Primary Care healthcare provider based in Houston, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/03/2016. The National Provider Identifier (NPI) number assigned to this provider is 1609221175.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Hania Tofik has received a total of $3,937 in payments from pharmaceutical and medical device companies, with $1,487 received in 2024. These payments were reported across 189 transactions from 26 companies. The most common payment nature is "Food and Beverage" ($3,937).
As a Medicare-enrolled provider, Tofik has provided services to 113 Medicare beneficiaries, totaling 133 services with total Medicare billing of $9,458. Data is available for 2 years (2022–2023), covering 3 distinct procedure/service records.
Ad
Practice Information
- Specialty Primary Care
- Other Specialties Acute Care
- Location Houston, TX
- Active Since 05/03/2016
- Last Updated 12/11/2024
- Taxonomy Code 363LP2300X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1609221175
Products in Payments
- THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) $512.87
- STELARA (Biological) $498.94
- RINVOQ (Biological) $482.50
- HeartMate 3 Left Ventricular Assist Device (Device) $411.50
- XIFAXAN (Drug) $292.43
- ZEPOSIA (Drug) $273.69
- ENTYVIO (Biological) $264.21
- XELJANZ (Drug) $124.19
- SKYRIZI (Biological) $94.55
- HUMIRA (Biological) $70.20
- IQIRVO (Drug) $64.61
- OMVOH (Drug) $61.01
- RESMETIROM (Drug) $60.16
- GATTEX (Drug) $58.94
- VOQUEZNA (Drug) $53.24
- OCALIVA (Drug) $48.51
- CARDIOMEMS (Device) $46.49
- DIFICID (Drug) $44.24
- EOHILIA (Drug) $43.02
- GIMOTI (Drug) $38.35
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Primary Care Doctors in Houston
Mrs. Mary Gibbens, Msn, Aprn, A-Gnp-C, MSN, APRN, A-GNP-C
Primary Care — Payments: $16,984
Primary Care $16,984
Ms. Meisha Smith, Fnp-C, FNP-C
Primary Care — Payments: $4,646
Primary Care $4,646
Nonye Nelson, Np, NP
Primary Care — Payments: $4,468
Primary Care $4,468
Joanna Larson, Fnp, FNP
Primary Care — Payments: $3,277
Primary Care $3,277
Mrs. Natalie Greer, Aprn, APRN
Primary Care — Payments: $2,400
Primary Care $2,400
Bindu Simon, Aprn, APRN
Primary Care — Payments: $2,266
Primary Care $2,266